Galsky MD, Gschwend JE, Milowsky MI, Schenker M, et al. Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274. Ann Oncol 2026;37:69-78.
PMID: 41110694